drug
MBP-134
Phase 1updated 3mo agoby Mapp Biopharmaceutical Inc
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
News(3)
- The race for an Ebola therapy beginsMale marathoners "hit the wall," mental health in 2026, and more Morning Rounds newsstat · 1mo ago
- Texas AG investigating energy drinksThe limitations of private health insurance, the quiet collapse of America's research ethics watchdog and other Morning Rounds newsstat · 2mo ago
- HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapyAmericans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.stat · 2mo ago
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that